The retinal disease seen in human patients with dominant mutations in GUCA1A was originally described as an isolated cone dystrophy, but recent evidence suggests that secondary loss of rod function may occur in some patients, particularly at later stages of disease [16]. This evidence concerns the gene GUCA1A and Abnormal retinal morphology.